337.58
-0.46 (-0.14%)
| Penutupan Terdahulu | 338.04 |
| Buka | 338.64 |
| Jumlah Dagangan | 4,039 |
| Purata Dagangan (3B) | 1,003,996 |
| Modal Pasaran | 13,247,669,248 |
| Harga / Pendapatan (P/E TTM) | 74.52 |
| Harga / Pendapatan (P/E Ke hadapan) | 64.94 |
| Harga / Jualan (P/S) | 9.40 |
| Harga / Buku (P/B) | 9.23 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Apr 2026 |
| Margin Keuntungan | 3.41% |
| Margin Operasi (TTM) | 12.45% |
| EPS Cair (TTM) | 1.09 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 16.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 256.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 18.19% |
| Nisbah Semasa (MRQ) | 6.30 |
| Aliran Tunai Operasi (OCF TTM) | 179.16 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 135.83 M |
| Pulangan Atas Aset (ROA TTM) | 5.82% |
| Pulangan Atas Ekuiti (ROE TTM) | 3.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Penumbra, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.20 |
|
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.64% |
| % Dimiliki oleh Institusi | 91.96% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 374.00 (RBC Capital, 10.79%) | Pegang |
| 374.00 (Canaccord Genuity, 10.79%) | Pegang | |
| 374.00 (Jefferies, 10.79%) | Pegang | |
| 374.00 (Citigroup, 10.79%) | Pegang | |
| 374.00 (Leerink Partners, 10.79%) | Pegang | |
| 374.00 (Baird, 10.79%) | Pegang | |
| 374.00 (Truist Securities, 10.79%) | Pegang | |
| 374.00 (Wells Fargo, 10.79%) | Pegang | |
| Median | 374.00 (10.79%) | |
| Rendah | 349.00 (BTIG, 3.38%) | Pegang |
| Purata | 370.09 (9.63%) | |
| Jumlah | 2 Beli, 9 Pegang | |
| Harga Purata @ Panggilan | 347.54 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Evercore ISI Group | 26 Feb 2026 | 360.00 (6.64%) | Beli | 341.94 |
| Canaccord Genuity | 20 Jan 2026 | 374.00 (10.79%) | Pegang | 355.44 |
| RBC Capital | 20 Jan 2026 | 374.00 (10.79%) | Pegang | 355.44 |
| BTIG | 16 Jan 2026 | 349.00 (3.38%) | Pegang | 350.78 |
| Baird | 16 Jan 2026 | 374.00 (10.79%) | Pegang | 350.78 |
| Citigroup | 16 Jan 2026 | 374.00 (10.79%) | Pegang | 350.78 |
| Jefferies | 16 Jan 2026 | 374.00 (10.79%) | Pegang | 350.78 |
| Leerink Partners | 16 Jan 2026 | 374.00 (10.79%) | Pegang | 350.78 |
| Truist Securities | 16 Jan 2026 | 374.00 (10.79%) | Pegang | 350.78 |
| Wells Fargo | 15 Jan 2026 | 374.00 (10.79%) | Pegang | 350.49 |
| B of A Securities | 05 Jan 2026 | 370.00 (9.60%) | Beli | 315.00 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | Boston Scientific announces results for fourth quarter and full year 2025 |
| 15 Jan 2026 | Pengumuman | Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results |
| 15 Jan 2026 | Pengumuman | Boston Scientific announces agreement to acquire Penumbra, Inc. |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |